Central Nervous System Biomarkers Market, by Application (Drug Discovery & Development, Personalized Medicines, Disease Risk Assessment, and Diagnostics), by Disease (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease, and Traumatic Brain Injury and Other Neurological Conditions), by End User (Diagnostic Labs, Clinics/Hospitals, and Research Centers), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

  • To Be Published : Jul 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Biomarkers are measurable indicators used to evaluate and determine pathogenic processes and therapeutic interventions and predict treatment response. Biomarkers are used in various scientific fields. Biomarkers are utilized in drug development and regulatory decision-making process as they have the potential to improve the efficiency of drug discovery and development process. Biomarkers offer information about a patient at virtually every stage of care. Biomarker development for brain disorders is increasing rapidly with advanced technologies that permit molecular and functional disease measures taken from brain, cerebrospinal fluid (CSF), and plasma.

Central Nervous System Biomarkers Market – Drivers

Increasing number of pipeline studies for the development of biomarkers in various disease conditions is expected to boost the central nervous system biomarkers market growth. For instance, in March 1, 2017, Hospices Civils de Lyon, initiated the clinical trial to evaluate predictive value of CSF biomarkers of Alzheimer’s disease (AD) in geriatric patients with new-onset epilepsy.

Biomarkers are becoming crucial in drug discovery and development process. Therefore, increasing number of research for drug development is also expected to propel the central nervous system biomarkers market growth. For instance, in January 2016, The Tufts Center for the Study of Drug Development, estimated that the developing cost of a new drug was US$ 2.6 billion and also suggested that the costs of drug development are increasing at a compound annual growth rate of 8.5%.

However, high cost of validation process such as sample collection & storage and unfavorable reimbursement situation for development and discovery of biomarkers can impede the central nervous system biomarkers market growth.

Central Nervous System Biomarkers Market – Regional Analysis

On the basis of region, the global central nervous system biomarkers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America central nervous system biomarkers market is expected to show significant growth, owing to expansion activities by key players in the region. For Instance, in January 2017, bioMérieux, an in vitro diagnostics company, entered into a partnership with Banyan Biomarkers. Banyan Biomarkers develops, validate, and market blood-based biomarkers for traumatic brain injury. Under this agreement, bioMérieux  took an equity participation of around US$ 7 million in Banyan Biomarkers and also obtained rights to develop market for Banyan’s proprietary tests worldwide.

Increasing prevalence of Alzheimer’s disease is expected to drive growth for the central nervous system biomarkers market in Asia Pacific. For instance, according to Alzheimer's Disease International (ADI), in 2015, around 23 million people in Asia Pacific suffered from dementia.

Keys players operating in the global central nervous system biomarkers market include, Thermo fisher scientific, Enzo Biochem Inc., Abiant Inc., EKF Diagnostics Holdings Inc., Abastar MDX Inc., Acumen Pharmaceuticals Inc., Adlyfe Inc., Apitope International, Alseres Pharmaceuticals Inc., Aposense, Banyan Biomarkers, Avid Radiopharmaceuticals Inc., Diagenic ASA, Avacta Group plc., Applied Neurosolutions Inc., Merc & Co. Inc., and Exonhit Therapeutics. 

Central Nervous System Biomarkers Market – Taxonomy

By Application

  • Drug Discovery & Development
  • Personalized Medicines
  • Disease Risk Assessment
  • Diagnostics

By Disease Indication

  • Alzheimer’s Disease
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Traumatic Brain Injury
  • Other Neurological Conditions

By End User

  • Diagnostic Labs
  • Clinics/Hospitals
  • Research Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.
Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.